|
US2021123848A1
|
|
Holographic characterization of irregular particles
|
|
WO2021067466A1
|
|
Recombinant botulinum neurotoxin with improved safety margin and reduced immunogenicity
|
|
US2021092957A1
|
|
Crystalline forms of deltamethrin and methods of use thereof
|
|
US2021092950A1
|
|
Pesticidal compounds and methods of use
|
|
US2021085763A1
|
|
Modulation of Oxidative Stress and Amino Acid Metabolism for the Treatment or Prevention of Diseases and Disorders
|
|
US2021064897A1
|
|
Biometric monitoring and protective device
|
|
US2021060119A1
|
|
Oxytocin compositions for treatment of tinnitus
|
|
US2021060514A1
|
|
Method and apparatus for the rapid discovery and design of polymerizations
|
|
WO2021035059A1
|
|
Targeting slc38a2 in pancreatic cancer
|
|
WO2021026185A1
|
|
Indole compounds as modulators of rage activity and uses thereof
|
|
WO2021022256A1
|
|
Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeutics
|
|
WO2021026026A1
|
|
Methods and compositions for treating arthritis
|
|
US2021030845A1
|
|
Vasointestinal peptide receptor inhibitors for enhancement of gastrointestinal health
|
|
US2020352556A1
|
|
Compact mechanical joint balancer
|
|
US2021025075A1
|
|
Systems and methods for continuous-flow laser-induced nucleation
|
|
WO2021011663A1
|
|
Oxygen cooling system for lung preservation
|
|
WO2021007276A1
|
|
Tumor immunotherapy using sindbis viral vectors and agonist monoclonal antibodies
|
|
WO2020251850A1
|
|
System, method and computer-accessible medium for a domain decomposition aware processor assignment in multicore processing system(s)
|
|
WO2020243705A1
|
|
Probiotic compositions and methods of use
|
|
WO2020243731A2
|
|
Probiotic applicatior and method for using same
|
